<DOC>
	<DOCNO>NCT01721538</DOCNO>
	<brief_summary>SCENARIO trial investigate role non-drug weight reduction secondary prevention stroke . It single-blinded , randomize , control multicentre trial two arm . The therapy arm participate comprehensive weight reduce program , whereas control group take part lecture healthy nutrition . The primary study objective ass efficacy non-drug therapeutic weight reduction secondary prevention stroke . Secondary objective functional outcome , cognitive status , post stroke depression , health-related quality life .</brief_summary>
	<brief_title>Secondary Prevention Stroke Through Non-drug Therapeutic Weight Reduction</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Diagnosis ischemic stroke Age : 20 85 year BMI ≥ 25.0 kg/m² waist circumference men ≥ 94cm woman ≥ 80cm Functional impairment , would allow participate weight reduction program ( mRS 04 , NIHSS 012 ) Patient must capable understanding informed consent Written inform consent participation study Intracerebral hemorrhage primary cause stroke ( secondary hemorrhage exclusion criterion ) Speech disturbance ( aphasia sever dysarthria ) Dimming consciousness Stroke due arterial dissection coagulation disorder Drugrelated weight change previous 3 month Changes appetite influence medication list appendix previous 3 month Bariatric surgery past Diabetes mellitus history severe ketoacidosis Pregnancy nursing Severe comorbid disorder , e.g . : AVBlock ≥ 2nd degree Heart insufficiency ( NYHA &gt; 2 ) Pericarditis , pericardial effusion Severe kidney insufficiency ( Creatinine &gt; 3 mg/dl ; Urea &gt; 150 mg/dl ) Hepatic insufficiency ( GOT &gt; 3 x ULN ; GPT &gt; 3 x ULN ) Severe psychiatric disease within last six month ( psychosis , suicide attempt ) Chronic alcohol addiction drug addiction HIV hepatitis infection Bleeding peptic ulcer ( unless radiological evidence heal 6 month prior start obesity program ) Cognitive impairment MMSE &lt; 20 Depression BDI &gt; 20 Patients unable give consent study participation ( MMSE &lt; 20 , aphasia ) Recurrent stroke myocardial infarction period screen study participation start weight reduction program Simultaneous participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>stroke</keyword>
	<keyword>prevention</keyword>
	<keyword>obesity</keyword>
	<keyword>weight reduction</keyword>
</DOC>